O29 PEGYLATED RECOMBINANT DOMAIN I OF beta-2-GLYCOPROTEIN I, A POTENTIAL THERAPEUTIC AGENT FOR ANTI-PHOSPHOLIPID SYNDROME, FULLY RETAINS ITS ABILITY TO INHIBIT BINDING OF IGG OR IGA ANTIBODIES FROM PATIENTS WITH ANTI-PHOSPHOLIPID SYNDROMEAPS TO beta-2-GLYCOPROTEIN GPI IN VITRO